Mixed Connective Tissue Disease and Undifferentiated Connective Tissue Disease

Textbook of Pediatric Rheumatology

Volumn , Issue , 2015, Pages 418-426

  Pepmueller, Peri H ^a   Lindsley, Carol B ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85167743493     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-24145-8.00029-6     Document Type: Chapter

References (180)

1. G.C. Sharp, W.S. Irvin, E.M. Tan, et al. (1972) Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52 148-159
2. S.H. Nimelstein, S. Brody, D. McShane, et al. (1980) Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 59 239-248
3. R.W. Hoffman and G.C. Sharp (1995) Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct? J. Rheumatol. 22 586-589
4. G.C. Sharp (1987) Diagnostic criteria for classification of MCTD. R. Kasukawa, G.C. Sharp (Eds) Mixed Connective Tissue Disease and Anti-Nuclear Antibodies Amsterdam: Excerpta Medica 23-32
5. R. Kasukawa, T. Tojo, S. Miyawaki, et al. (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. R. Kasukawa, G.C. Sharp (Eds) Mixed Connective Tissue Disease and Anti-Nuclear Antibodies Amsterdam: Excerpta Medica 41-48
6. D. Alarcón-Segovia and M. Villarreal (1987) Classification and diagnostic criteria for mixed connective tissue disease. R. Kasukawa, G.C. Sharp (Eds) Mixed Connective Tissue Disease and Anti-Nuclear Antibodies Amsterdam: Excerpta Medica 33-40
7. J.S. Smolen and G. Steiner (1998) Mixed connective tissue disease: to be or not to be? Arthritis Rheum. 41 768-777
8. J.M. Amigues, A. Cantagrel, M. Abbal, et al. (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J. Rheumatol. 23 2055-2062
9. S. Bowyer and P. Roettcher (1996) Pediatric rheumatology clinic populations in the United States: results of a 3 year survey, pediatric rheumatology database research group. J. Rheumatol. 23 1968-1974
10. R.W. Hoffman, J.T. Cassidy, Y. Takeda, et al. (1993) U1-70-kd autoantibody-positive mixed connective tissue disease in children: a longitudinal clinical and serologic analysis. Arthritis Rheum. 36 1599-1602
11. D.J. de Rooij, T. Fiselier, L.B. van de Putte, et al. (1989) Juvenile-onset mixed connective tissue disease: clinical, serological and follow-up data. Scand. J. Rheumatol. 18 157-160
12. R.W. Hoffman, L.J. Rettenmaier, Y. Takeda, et al. (1990) Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum. 33 666-673
13. R.W. Hoffman and M.E. Maldonado (2008) Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review. Clin. Immunol. 128 8-17
14. R.W. Hoffman and E.L. Greidinger (2000) Mixed connective tissue disease. Curr. Op. Rheumatol. 12 386-390
15. A. Marshak-Rothstein (2006) Toll-like receptors in systemic auto-immune disease. Nat. Rev. Immunol. 6 823-835
16. E.L. Greidinger and R.W. Hoffman (2005) Autoantibodies in the pathogenesis of mixed connective tissue disease. Rheum. Dis. Clin. North Am. 31 437-450
17. M.R. Arbuckle, M.T. McClain, M.V. Rubertone, et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 1526-1533
18. J.H.W. Distler, T. Strapatsas, D. Huscher, et al. (2011) Dysbalance of angiogenic and angiostatic mediators inpatients with mixed connective tissue disease. Ann. Rheum. Dis. 70 1197-1202
19. D.Y. Sanders, C.C. Huntley and G.C. Sharp (1973) Mixed connective tissue disease in a child. J. Pediatr. 83 642-645
20. B.H. Singsen, H.K. Kornreich, K. Koster-King, et al. (1977) Mixed connective tissue disease in children. Arthritis Rheum. 20 355-360
21. A. Fraga, J. Gudino, F. Ramos-Niembro, et al. (1978) Mixed connective tissue disease in childhood: relationship to Sjögren's syndrome. Am. J. Dis. Child. 132 263-265
22. M. Rosenthal (1978) Juvenile sharp syndrome (mixed connective tissue disease). Helv. Paediatr. Acta 33 251-258
23. S.A. Peskett, B.M. Ansell, P. Fizzman, et al. (1978) Mixed connective tissue disease in children. Rheumatol. Rehabil. 17 245-248
24. W.J. Oetgen, J.A. Boice and O.J. Lawless (1981) Mixed connective tissue disease in children and adolescents. Pediatrics 67 333-337
25. L. Kotajima, S. Aotsuka, M. Sumiya, et al. (1996) Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J. Rheumatol. 23 1088-1094
26. S. Yokota, T. Imagawa, S. Katakura, et al. (1997) Mixed connective tissue disease in childhood: a nationwide retrospective study in Japan. Acta Paediatr. Jpn. 39 273-276
27. R.J. Mier, M. Shishov, G.C. Higgins, et al. (2005) Pediatric-onset mixed connective tissue disease. Rheum. Dis. Clin. North Am. 31 483-496
28. S. Yokota (1993) Mixed connective tissue disease in childhood. Acta Paediatr. Jpn. 35 472-479
29. J. van der Net, B. Wissink, A. van Royen, et al. (2010) Aerobic capacity and muscle strength in juvenile-onset mixed connective tissue disease (MCTD). Scand. J. Rheumatol. 39 387-392
30. W.D. Sullivan, D.J. Hurst, C.E. Harmon, et al. (1984) A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 63 92-107
31. T.M. Aaløkken, V. Lilleby, V. Søyseth, et al. (2009) Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests. Acta Radiol. 4 430-436
32. B.H. Singsen, V.L. Swanson, B.H. Bernstein, et al. (1980) A histologic evaluation of mixed connective tissue disease in childhood. Am. J. Med. 68 710-717
33. M. Uzuki, A. Kamataki, M. Watanabe, et al. (2011) Histologic analysis of esophageal muscular layers from 27 autopsy cases with mixed connective tissue disease (MCTD). Pathol. Res. Pract. 207 383-390
34. J.T. Cassidy, R.W. Hoffman, D.W. Wortmann, et al. (2000) Long-term outcome of children with mixed connective tissue disease (MCTD). J. Rheumatol. 27 100
35. I. Pettersson, G. Wang, E.I. Smith, et al. (1986) The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus: cross-sectional, longitudinal study. Arthritis Rheum. 29 986-996
36. Y. Takeda, G.S. Wang, R.J. Wang, et al. (1989) Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin. Immunol. Immunopathol. 50 213-230
37. M. Takano, S.S. Golden, G.C. Sharp, et al. (1981) Molecular relationships between two nuclear antigens, ribonucleoprotein and Sm: purification of active antigens and their biochemical characterization. Biochemistry 20 5929-5936
38. H.A. Tiddens, J.J. van der Net, E.R. Graeff-Meeder, et al. (1993) Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J. Pediatr. 122 191-197
39. H. Michels (1997) Course of mixed connective tissue disease in children. Ann. Med. 29 359-364
40. G.R. Komatireddy, G.S. Wang, G.C. Sharp, et al. (1997) Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. J. Rheumatol. 24 319-322
41. T. Nishimaki, S. Aostsuka, H. Kondo, et al. (1999) Immunological analysis of pulmonary hypertension in connective tissue disease. J. Rheumatol. 26 2357-2362
42. A. Hajas, P. Szodoray, B. Nakken, et al. (2013) Clinical course, prognosis, and causes of death in mixed connective tissue disease. J. Rheumatol. 40 1134-1142
43. X. Jais, D. Launay, A. Yaici, et al. (2008) Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 58 521-531
44. R.J. Barst, L.J. Rubin, W.A. Long, et al. (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: The Primary Pulmonary Hypertension Study Group. N. Engl. J. Med. 334 296-302
45. T.M. Bull, K.A. Fagan and D.B. Badesch (2005) Pulmonary vascular manifestations of mixed connective tissue disease. Rheum. Dis. Clin. North Am. 31 451-464
46. L.J. Rubin, D.B. Badesch, R.J. Barst, et al. (2002) Bosentan therapy for pulmonary arterial hypertension. N. Engl. J. Med. 46 896-903
47. S.G. Haworth and A.A. Hislop (2009) Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006. Heart 312-317
48. S. Nakata, K. Uematsu, T. Mori, et al. (1997) Effective treatment with low-dose methotrexate pulses of a child of mixed connective tissue disease with severe myositis refractory to corticosteroid. Nihon Rinsho Meneki Gakkai Kaishi 20 178-183. Article in Japanese
49. B. Jovancevic, C. Lindholm and R. Pullerits (2013) Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long term follow-up and review of the literature. Lupus 22 664-674
50. Y.Y. Tsai, Y.H. Yang, H.H. Yu, et al. (2010) Fifteen-year experience of pediatric-onset mixed connective tissue disease. Clin. Rheumatol. 29 53-58
51. E.C. LeRoy, H.R. Maricq and M.B. Kahaleh (1980) Undifferentiated connective tissue syndromes. Arthritis Rheum. 23 341-343
52. G.S. Alarcon, G.V. Williams, J.Z. Singer, et al. (1991) Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well-established connective tissue diseases. J. Rheumatol. 18 1332-1339
53. H.J. Williams, G.S. Alarcon, R. Joks, et al. (1999) Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well-established and undifferentiated CTD. J. Rheumatol. 26 816-825
54. J. Calvo-Alen, H.M. Bastian, K.V. Straaton, et al. (1995) Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum. 38 1475-1484
55. M. Mosca, A. Tavoni, R. Neri, et al. (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus 7 95-100
56. C.L. Vanderlugt and S.D. Miller (2002) Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2 85-95
57. The entire reference list is available online at www.expertconsult.com
58. M. Reichlin, P.J. Maddison, I. Targoff, et al. (1984) Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J. Clin. Immunol. 4 40-44
59. G.C. Sharp, W.S. Irvin, E.M. Tan, et al. (1972) Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52 148-159
60. S.H. Nimelstein, S. Brody, D. McShane, et al. (1980) Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 59 239-248
61. R.M. Bennett and D.J. O’Connell (1980) Mixed connective tissue disease: a clinicopathologic study of 20 cases. Semin. Arthritis Rheum. 10 25-51
62. I. Lundberg and E. Hedfors (1991) Clinical course of patients with anti-RNP antibodies: a prospective study of 32 patients. J. Rheumatol. 18 1511-1519
63. R.W. Hoffman and G.C. Sharp (1995) Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct? J. Rheumatol. 22 586-589
64. G.C. Sharp (2002) MCTD: A concept which stood the test of time. Lupus 11 333-339
65. G.C. Sharp (1987) Diagnostic criteria for classification of MCTD. R. Kasukawa, G.C. Sharp (Eds) Mixed Connective Tissue Disease and Anti-Nuclear Antibodies Amsterdam: Excerpta Medica 23-32
66. R. Kasukawa, T. Tojo, S. Miyawaki, et al. (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. R. Kasukawa, G.C. Sharp (Eds) Mixed Connective Tissue Disease and Anti-Nuclear Antibodies Amsterdam: Excerpta Medica 41-48
67. D. Alarcón-Segovia and M. Villarreal (1987) Classification and diagnostic criteria for mixed connective tissue disease. R. Kasukawa, G.C. Sharp (Eds) Mixed Connective Tissue Disease and Anti-Nuclear Antibodies Amsterdam: Excerpta Medica 33-40
68. M.F. Kahn and T. Appelboom (1991) Syndrome de Sharp. M.F. Kahn, A.P. Peltier, O. Meyer (Eds) Les Maladies Systémiques third ed. Paris: Flammarion 545-556
69. J.S. Smolen and G. Steiner (1998) Mixed connective tissue disease: to be or not to be? Arthritis Rheum. 41 768-777
70. N. Shen, S. Chen, H. Yang, et al. (1998) Mixed connective tissue disease: a disease entity? Chin. Med. J. Engl. 111 214-217
71. J.M. Amigues, A. Cantagrel, M. Abbal, et al. (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J. Rheumatol. 23 2055-2062
72. P.M. Pelkonen, H.J. Jalanko, R.K. Lantto, et al. (1994) Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland. J. Rheumatol. 21 2143-2146
73. S. Bowyer and P. Roettcher (1996) Pediatric rheumatology clinic populations in the United States: results of a 3 year survey, pediatric rheumatology database research group. J. Rheumatol. 23 1968-1974
74. D.P.M. Symmons, M. Jones, J. Osborne, et al. (1996) Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J. Rheumatol. 23 1975-1980
75. P.N. Malleson, M.Y. Fung and A.M. Rosenberg (1996) The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J. Rheumatol. 23 1981-1987
76. J.R. Horn, J.J. Kapur and S.E. Walker (1978) Mixed connective tissue disease in siblings. Arthritis Rheum. 21 709-714
77. R.W. Hoffman, J.T. Cassidy, Y. Takeda, et al. (1993) U1-70-kd autoantibody-positive mixed connective tissue disease in children: a longitudinal clinical and serologic analysis. Arthritis Rheum. 36 1599-1602
78. E. Genth, H. Zarnowski, R. Mierau, et al. (1987) HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Ann. Rheum. Dis. 46 189-196
79. C.M. Black, P.J. Maddison, K.I. Welsh, et al. (1988) HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis Rheum. 31 131-134
80. J.B. Harley, A.L. Sestak, L.G. Willis, et al. (1989) A model for disease heterogeneity in systemic lupus erythematosus: relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum. 32 826-836
81. D.J. de Rooij, T. Fiselier, L.B. van de Putte, et al. (1989) Juvenile-onset mixed connective tissue disease: clinical, serological and follow-up data. Scand. J. Rheumatol. 18 157-160
82. R.W. Hoffman, L.J. Rettenmaier, Y. Takeda, et al. (1990) Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum. 33 666-673
83. H. Kaneoka, K.C. Hsu, Y. Takeda, et al. (1992) Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody positive connective tissue disease patients. Arthritis Rheum. 35 83-94
84. J.S. Lanchbury, M.A. Hall, K.I. Welsh, et al. (1990) Sequence analysis of HLA-DR4B1 subtypes: additional first domain variability is detected by oligonucleotide hybridization and nucleotide sequencing. Hum. Immunol. 27 136-144
85. R.W. Hoffman and M.E. Maldonado (2008) Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review. Clin. Immunol. 128 8-17
86. R.W. Hoffman and E.L. Greidinger (2000) Mixed connective tissue disease. Curr. Op. Rheumatol. 12 386-390
87. B. Kastner, U. Kornstädt, M. Bach, et al. (1992) Structure of the small nuclear RNP particle U1: identification of the two structural protuberances with RNP-antigens A and 70 k. J. Cell Biol. 116 839-849
88. J.C. Hall, L. Casiola-Rosen and A. Rosen (2004) Altered structure of autoantigens during apoptosis. Rheum. Dis. Clin. North Am. 30 455-471
89. D. Hoff, J.M.H. Raats and G.J.M. Pruijin (2005) Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen. Autoimmun. Rev. 4 380-388
90. E.L. Greidinger, M.F. Foecking, S. Ranatunga, et al. (2002) Apoptotic U1-70-kD is antigenically distinct from the intact form of the U1-70-kD molecule. Arthritis Rheum. 46 1264-1269
91. D. Hoff, K. Cheung, D.J.R. de Rooij, et al. (2005) Autoantibodies specific for apoptotic U1-70-kD are superior serological markers for mixed connective tissue disease. Arthritis Res. Ther. 7 302-309
92. E.L. Greidinger, L. Casiola-Rosen, S.M. Morris, et al. (2000) Autoantibody recognition of distinctly modified forms of the U1-70-kD antigen is associated with different clinical disease manifestations. Arthritis Rheum. 43 881-888
93. S.R. Christensen and M.J. Shlomchik (2007) Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin. Immunol. 19 11-23
94. A. Marshak-Rothstein (2006) Toll-like receptors in systemic auto-immune disease. Nat. Rev. Immunol. 6 823-835
95. L. Alexopoulou, A.C. Holt, R. Medzhitov, et al. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 732-738
96. R.W. Hoffman, T. Gazitt, M.F. Foecking, et al. (2004) U1 RNA induces innate immunity signaling. Arthritis Rheum. 50 2891-2896
97. E.L. Greidinger and R.W. Hoffman (2005) Autoantibodies in the pathogenesis of mixed connective tissue disease. Rheum. Dis. Clin. North Am. 31 437-450
98. M.R. Arbuckle, M.T. McClain, M.V. Rubertone, et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 1526-1533
99. E.L. Greidinger and R.W. Hoffman (2001) The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kD and B′/B proteins as predominant U1 RNP immunogens. Arthritis Rheum. 44 368-375
100. J.H.W. Distler, T. Strapatsas, D. Huscher, et al. (2011) Dysbalance of angiogenic and angiostatic mediators inpatients with mixed connective tissue disease. Ann. Rheum. Dis. 70 1197-1202
101. E.L. Greidinger, Y. Zang, K. Jaimes, et al. (2006) A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum. 54 661-669
102. D.Y. Sanders, C.C. Huntley and G.C. Sharp (1973) Mixed connective tissue disease in a child. J. Pediatr. 83 642-645
103. B.H. Singsen, H.K. Kornreich, K. Koster-King, et al. (1977) Mixed connective tissue disease in children. Arthritis Rheum. 20 355-360
104. A. Fraga, J. Gudino, F. Ramos-Niembro, et al. (1978) Mixed connective tissue disease in childhood: relationship to Sjögren's syndrome. Am. J. Dis. Child. 132 263-265
105. M. Rosenthal (1978) Juvenile sharp syndrome (mixed connective tissue disease). Helv. Paediatr. Acta 33 251-258
106. S.A. Peskett, B.M. Ansell, P. Fizzman, et al. (1978) Mixed connective tissue disease in children. Rheumatol. Rehabil. 17 245-248
107. A.M. Rosenberg, R.E. Petty, G.R. Cumming, et al. (1979) Pulmonary hypertension in a child with mixed connective tissue disease. J. Rheumatol. 6 700-704
108. H. Michels and L. Schuchmann (1980) MCTD (Sharp) syndrome in childhood. (author's transl). Klin. Padiatr. 192 389-392. Article in German
109. W.J. Oetgen, J.A. Boice and O.J. Lawless (1981) Mixed connective tissue disease in children and adolescents. Pediatrics 67 333-337
110. K. Eberhardt, H. Svantesson and B. Svensson (1981) Follow-up study of 6 children presenting with a MCTD-like syndrome. Scand. J. Rheumatol. 10 62-64
111. R.C. Allen, C. St Cyr, P.J. Maddison, et al. (1986) Overlap connective tissue syndromes. Arch. Dis. Child. 61 284-288
112. R. Allen (1990) Overlap syndrome. P. Woo, P.H. White, B.M. Ansell (Eds) Paediatric Rheumatology Update Oxford: Oxford University Press 209-216
113. R. Mier, B. Ansell, M.A. Hall, et al. (1996) Long term follow-up of children with mixed connective tissue disease. Lupus 5 221-226
114. Y.H. Yang, M.J. Tsai, S.C. Lin, et al. (2000) Childhood mixed connective tissue disease. J. Formos. Med. Assoc. 99 158-161
115. L. Kotajima, S. Aotsuka, M. Sumiya, et al. (1996) Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J. Rheumatol. 23 1088-1094
116. S. Yokota, T. Imagawa, S. Katakura, et al. (1997) Mixed connective tissue disease in childhood: a nationwide retrospective study in Japan. Acta Paediatr. Jpn. 39 273-276
117. R.J. Mier, M. Shishov, G.C. Higgins, et al. (2005) Pediatric-onset mixed connective tissue disease. Rheum. Dis. Clin. North Am. 31 483-496
118. S. Yokota (1993) Mixed connective tissue disease in childhood. Acta Paediatr. Jpn. 35 472-479
119. J. van der Net, B. Wissink, A. van Royen, et al. (2010) Aerobic capacity and muscle strength in juvenile-onset mixed connective tissue disease (MCTD). Scand. J. Rheumatol. 39 387-392
120. D. Alarcón-Segovia (1984) Symptomatic Sjögren's syndrome in mixed connective tissue disease. J. Rheumatol. 11 582-583
121. H.R. Maricq, E.C. LeRoy, W.A.D. Angelo, et al. (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 23 183-189
122. H.R. Maricq (1981) Wide-field capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum. 24 1159-1165
123. A. Scheja, R. Elborgh and M. Wildt (1999) Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease. J. Rheumatol. 26 1377-1381
124. P. Weber, G. Ganser, M. Frosch, et al. (2000) Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J. Rheumatol. 27 2692-2695
125. Y. Saito, M. Terada, T. Takada, et al. (2002) Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J. Comput. Assist. Tomogr. 26 349-357
126. B. Hamoir, M. Giroux, O. Outteryck, et al. (2014) Mixed connective tissue disease presenting as trigeminal neuropathy. Acta Neurol. Belg. 114 245-246
127. B. Hojaili and P. Barland (2006) Trigeminal neuralgia as the first manifestation of the mixed connective tissue disorder. J. Clin. Rheumatol. 12 145-147
128. W.D. Sullivan, D.J. Hurst, C.E. Harmon, et al. (1984) A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 63 92-107
129. T.M. Aaløkken, V. Lilleby, V. Søyseth, et al. (2009) Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests. Acta Radiol. 4 430-436
130. B.H. Singsen, V.L. Swanson, B.H. Bernstein, et al. (1980) A histologic evaluation of mixed connective tissue disease in childhood. Am. J. Med. 68 710-717
131. M. Uzuki, A. Kamataki, M. Watanabe, et al. (2011) Histologic analysis of esophageal muscular layers from 27 autopsy cases with mixed connective tissue disease (MCTD). Pathol. Res. Pract. 207 383-390
132. J.T. Cassidy, R.W. Hoffman, D.W. Wortmann, et al. (2000) Long-term outcome of children with mixed connective tissue disease (MCTD). J. Rheumatol. 27 100
133. J.F. Savouret, D.S. Chudwin, D.W. Wara, et al. (1983) Clinical and laboratory findings in childhood mixed connective tissue disease: presence of antibody to ribonucleoprotein containing the small nuclear ribonucleic acid U1. J. Pediatr. 102 841-846
134. I. Pettersson, G. Wang, E.I. Smith, et al. (1986) The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus: cross-sectional, longitudinal study. Arthritis Rheum. 29 986-996
135. J. Margaux, G. Hayem, E. Palazzo, et al. (1998) Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus. Rev. Rhum. Engl. Ed 65 378-386
136. A. Kramer (1996) The structure and function of proteins involved in mammalian pre-mRNA-splicing. Annu. Rev. Biochem. 65 367-409
137. I. Pettersson, M. Hinterberger, T. Mimori, et al. (1984) The structure of mammalian small nuclear ribonucleo-proteins: Identification of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J. Biol. Chem. 259 5907-5914
138. W.J. Habets, M.H. Hoet, P.T. Sillekens, et al. (1989) Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens. Clin. Exp. Immunol. 76 172-177
139. A. Mesa, J.A. Somarelli, W. Wu, et al. (2013) Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease. Lupus 22 1371-1381
140. S.L. Deutscher and J.D. Keene (1988) A sequence-specific conformational epitope on U1 RNA is recognized by a unique autoantibody. Proc. Natl. Acad. Sci. U.S.A. 85 3299-3303
141. W.J. Van Venrooij, R. Hoet, J. Castrop, et al. (1990) Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases. J. Clin. Invest. 86 2154-2160
142. R.M. Hoet, I. Koornneef, D.J. de Rooij, et al. (1992) Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum. 35 1202-1210
143. Y. Takeda, G.S. Wang, R.J. Wang, et al. (1989) Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin. Immunol. Immunopathol. 50 213-230
144. M. Takano, S.S. Golden, G.C. Sharp, et al. (1981) Molecular relationships between two nuclear antigens, ribonucleoprotein and Sm: purification of active antigens and their biochemical characterization. Biochemistry 20 5929-5936
145. H.A. Tiddens, J.J. van der Net, E.R. Graeff-Meeder, et al. (1993) Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J. Pediatr. 122 191-197
146. H. Michels (1997) Course of mixed connective tissue disease in children. Ann. Med. 29 359-364
147. A. Hajas, J. Sandor, L. Csathy, et al. (2011) Vitamin D insufficiency in a large MCTD population. Autoimmun. Rev. 10 317-324
148. G.R. Komatireddy, G.S. Wang, G.C. Sharp, et al. (1997) Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. J. Rheumatol. 24 319-322
149. T. Nishimaki, S. Aostsuka, H. Kondo, et al. (1999) Immunological analysis of pulmonary hypertension in connective tissue disease. J. Rheumatol. 26 2357-2362
150. A. Hajas, P. Szodoray, B. Nakken, et al. (2013) Clinical course, prognosis, and causes of death in mixed connective tissue disease. J. Rheumatol. 40 1134-1142
151. X. Jais, D. Launay, A. Yaici, et al. (2008) Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 58 521-531
152. D.B. Badesch, V.F. Tapson, M.D. McGoon, et al. (2000) Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized controlled trial. Ann. Intern. Med. 132 425-434
153. R.J. Barst, L.J. Rubin, W.A. Long, et al. (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: The Primary Pulmonary Hypertension Study Group. N. Engl. J. Med. 334 296-302
154. T.M. Bull, K.A. Fagan and D.B. Badesch (2005) Pulmonary vascular manifestations of mixed connective tissue disease. Rheum. Dis. Clin. North Am. 31 451-464
155. F. Cozzi, R. Montisci, H. Marotta, et al. (2006) Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases. Eur. J. Clin. Invest. 36 49-53
156. L.J. Rubin, D.B. Badesch, R.J. Barst, et al. (2002) Bosentan therapy for pulmonary arterial hypertension. N. Engl. J. Med. 46 896-903
157. S.G. Haworth and A.A. Hislop (2009) Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006. Heart 312-317
158. S. Nakata, K. Uematsu, T. Mori, et al. (1997) Effective treatment with low-dose methotrexate pulses of a child of mixed connective tissue disease with severe myositis refractory to corticosteroid. Nihon Rinsho Meneki Gakkai Kaishi 20 178-183. Article in Japanese
159. J.H.W. Distler, B. Manger, B.M. Spriewald, et al. (2008) Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease. Arthritis Rheum. 58 2538-2542
160. S. Rummler, K. Althaus, B. Maak, et al. (2008) A case report of successful treatments with immunoabsorption onto protein A in mixed connective tissue disease in childhood. Ther. Apher. Dial. 12 337-342
161. B. Jovancevic, C. Lindholm and R. Pullerits (2013) Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long term follow-up and review of the literature. Lupus 22 664-674
162. N.M. Wulffraat, L.A. Sanders and W. Kuis (2000) Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr. Rheumatol. Rep. 2 316-323
163. M.A. Burdt, R.W. Hoffman, S.L. Deutscher, et al. (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 42 899-909
164. Y.Y. Tsai, Y.H. Yang, H.H. Yu, et al. (2010) Fifteen-year experience of pediatric-onset mixed connective tissue disease. Clin. Rheumatol. 29 53-58
165. E.C. LeRoy, H.R. Maricq and M.B. Kahaleh (1980) Undifferentiated connective tissue syndromes. Arthritis Rheum. 23 341-343
166. G.S. Alarcon, G.V. Williams, J.Z. Singer, et al. (1991) Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well-established connective tissue diseases. J. Rheumatol. 18 1332-1339
167. G.S. Alarcon, R.F. Willkens, J.R. Ward, et al. (1996) Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients well-established connective tissue diseases: follow-up analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Arthritis Rheum. 39 403-414
168. H.J. Williams, G.S. Alarcon, R. Neuner, et al. (1998) Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. J. Rheumatol. 25 261-268
169. H.J. Williams, G.S. Alarcon, R. Joks, et al. (1999) Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well-established and undifferentiated CTD. J. Rheumatol. 26 816-825
170. J. Calvo-Alen, G.S. Alarcon, S.L. Burgard, et al. (1996) Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors. J. Rheumatol. 23 469-475
171. J. Calvo-Alen, H.M. Bastian, K.V. Straaton, et al. (1995) Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum. 38 1475-1484
172. M. Mosca, R. Neri and S. Bombardieri (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin. Exp. Rheumatol. 17 615-620
173. M. Mosca, A. Tavoni, R. Neri, et al. (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus 7 95-100
174. P.G. Vlachoyiannopoulos, V. Tzavara, U. Dafni, et al. (1998) Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. J. Rheumatol. 25 886-891
175. C.L. Vanderlugt and S.D. Miller (2002) Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2 85-95
176. P.V. Lehmann, T. Forsthuber, A. Miller, et al. (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 258 155-157
177. E.L. Treadwell, M.A. Alspaugh, J.E. Wolfe, et al. (1984) Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen. J. Rheumatol. 11 658
178. C. Marguerie, C.C. Bunn, H.L. Beyon, et al. (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Quart. J. Med. 77 1019
179. V. Garcia-Patos, R. Bartralot, V. Fonollosa, et al. (1996) Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanics in hands. Br. J. Dermatol. 135 613-616
180. L.G. Rider, F.W. Miller, I.N. Targoff, et al. (1994) A broadened spectrum of juvenile myositis: myositis-specific autoantibodies in children. Arthritis Rheum. 37 1534-1538